Overview

Liposomal Bupivacaine To Control Post-Operative Pain Following BMG

Status:
Completed
Trial end date:
2017-10-31
Target enrollment:
Participant gender:
Summary
This is a single blinded-randomized controlled trial that recruit male patients for substitution urethroplasty using buccal mucosal graft. The study investigators aim to assess the efficacy and safety of liposomal bupivacaine injection to the buccal graft harvest site on post-operative main score, morphine equivalence requirement and oral morbidities.
Phase:
Phase 3
Details
Lead Sponsor:
Urology of Virginia
Treatments:
Bupivacaine